Skip to Content
Merck
CN

N3258

Nicotinamide N-oxide

≥98%

Synonym(s):

3-Pyridinecarboxamide, Oxynicotinamide

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C6H6N2O2
CAS Number:
Molecular Weight:
138.12
UNSPSC Code:
41106305
PubChem Substance ID:
EC Number:
217-859-4
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

USSFUVKEHXDAPM-UHFFFAOYSA-N

InChI

1S/C6H6N2O2/c7-6(9)5-2-1-3-8(10)4-5/h1-4H,(H2,7,9)

SMILES string

NC(=O)c1ccc[n+]([O-])c1

assay

≥98%

mp

291-293 °C (dec.) (lit.)

Biochem/physiol Actions

Nicotinamide N-oxide is a niacin-related compound used in studies of mechanisms of niacin-related granulocyte differentiation of cells such as human promyelocytic leukemia cells (HL-60). Nicotinamide N-oxide reduced expression of c-myc in HL-60 cell line.

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

K Takekawa et al.
Xenobiotica; the fate of foreign compounds in biological systems, 31(1), 11-23 (2001-05-04)
1. The mechanism of reduction of aliphatic tertiary amine N-oxides to tertiary amines in liver microsomes was examined and a novel type of reduction by cytochrome P450 was found. 2. Rat liver microsomes exhibited a significant N-oxide reductase activity toward
S Shimada et al.
Investigative ophthalmology & visual science, 28(7), 1204-1206 (1987-07-01)
The nicotinamide N-oxide reductase activity of a variety of ocular tissues was investigated. The 9,000g supernatant of ciliary body, retinal pigment epithelium-choroid, iris, retina and cornea, but not lens, exhibited reductase activity under anaerobic conditions when supplemented with 2-hydroxypyrimidine, an
Spectroscopic (NMR, UV, FT-IR and FT-Raman) analysis and theoretical investigation of nicotinamide N-oxide with density functional theory.
Atac A, Karabacak M, Kose E, Karaca C.
Spectrochimica Acta Part A: Molecular Spectroscopy, 83(1), 250-258 (2011)
Nicotinamide N-oxide formation by rat liver microsomes.
K Nomura et al.
Biochemical pharmacology, 32(5), 934-936 (1983-03-01)
P Dostert et al.
Xenobiotica; the fate of foreign compounds in biological systems, 15(10), 799-803 (1985-10-01)
Using the N-oxide derivative of niaprazine, a nicotinamide-based drug, as substrate, the possibility of a 1,2-oxygen shift from N to adjacent C occurring in vivo has been investigated. By comparison of the percentage of the 6-pyridone derivative formed after administration

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service